In the Media
Vicente LLP has been at the forefront of cannabis law and policy for more than a decade, and our team members are frequently called upon to provide commentary and analysis on a wide variety of marijuana and hemp issues. We have appeared in/on countless local, national, and international media outlets, including:
Latest Media Appearances
- Benzinga, "Cannabis May Be An Essential Service—But Securing Funding is Still an Uphill Battle," August 24, 2022
- High Times, "California Governor Vetoes Bill Authorizing Safe Injection Sites," August 23, 2022
- Forbes, "Federal Court Strikes Down Maine's Residency Requirement for Cannabis Business Owners," August 22, 2022
- Law360, "State Cannabis Regulations in Question After 1st Circ Ruling," August 19, 2022
- Wicked Local, "Cannabis-themed golf tourney trial run a success; funds to aid social justice group POSE," August 16, 2022
- High Times, "North Dakota Will Vote on Recreational Weed Legalization in November," August 16, 2022
- WJCT News - First Coast Connect with Melissa Ross, "Ballot initiative to legalize recreational marijuana; improving social determinants of health; Family Links; local sports," August 15, 2022
- Benzinga, "With Trademark Infringement A Common Issue in Cannabis, Are Cease And Desist Orders Effective?," August 12, 2022
- Worcester Magazine, "Cannabis Confidential: Lawmakers Pass Landmark Legislation Enhancing Equity in the Industry," August 12, 2022
- Hartford Business Journal, "With Eight Appeals Already Filed From Denied Cannabis Cultivators, State Could See More Before Friday Deadline," August 11, 2022
- Rolling Stone, "12 Tips to Get Honest, Constructive Feedback From Your Employees," August 11, 2022
- Leaf Retailer, "The Cannabis Administration and Opportunity Act One Step Closer to Passing," August 10, 2022
- Leaf Retailer, "New D.C. Legislation Offers Easier Access to Marijuana," August 9, 2022
- High There, "Florida Cannabis Advocates File Recreational Weed Legalization Initiative," August 9, 2022
- Politico, "DEA Stymies Cannabis Production for Clinical Trials," August 9, 2022